Short Interest To Observe: Aurinia Pharmaceuticals Ord (NASDAQ:AUPH) Just Reported Decreased Shorts

November 25, 2016 - By Adrian Mccoy   ·   0 Comments

Short Interest To Observe: Aurinia Pharmaceuticals Ord (NASDAQ:AUPH) Just Reported Decreased Shorts

The stock of Aurinia Pharmaceuticals Ord (NASDAQ:AUPH) registered a decrease of 24.33% in short interest. AUPH’s total short interest was 1.87M shares in November as published by FINRA. Its down 24.33% from 2.47 million shares, reported previously. With 1.23 million shares average volume, it will take short sellers 2 days to cover their AUPH’s short positions. The short interest to Aurinia Pharmaceuticals Ord’s float is 11.3%. The stock decreased 3.40% or $0.11 on November 23, hitting $3.13. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has risen 4.68% since April 22, 2016 and is uptrending. It has underperformed by 0.73% the S&P500.

Aurinia Pharmaceuticals Inc. is a Canada clinical-stage biopharmaceutical firm operating in the field of nephrology and autoimmunity. The company has a market cap of $121.43 million. The Company’s primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis . It currently has negative earnings. It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>